Related Experiment Video

Updated: Apr 21, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

19.8K

Translating the molecular message of triple-negative breast cancer into targeted therapy

Neelima Vidula1, Hope S Rugo2

  • 1Division of Hematology-Oncology, University of California San Francisco, San Francisco, California.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|October 30, 2014
PubMed

Insights

Triple-negative breast cancer (TNBC) has a poor prognosis. Genomic analysis may reveal subtypes and molecular targets for new targeted therapies.

Area of Science:

  • Oncology
  • Genomics
  • Translational Research

Background:

  • Triple-negative breast cancer (TNBC) presents a significant clinical challenge due to its aggressive nature and limited therapeutic strategies.
  • Current treatment options for TNBC are insufficient, leading to poor patient outcomes.

Purpose of the Study:

  • To investigate the genomic landscape of triple-negative breast cancer.
  • To identify biologically relevant subtypes within TNBC.
  • To discover novel molecular targets for potential therapeutic intervention.

Main Methods:

  • Utilizing comprehensive genomic analysis techniques.
  • Classifying TNBC tumors into distinct molecular subtypes.
  • Correlating genomic alterations with clinical data.

Main Results:

  • Genomic profiling revealed heterogeneity within TNBC, defining unique molecular subtypes.
  • Specific molecular targets were identified within these subtypes.
  • These targets represent potential avenues for personalized treatment approaches.

Conclusions:

  • Genomic subtyping of TNBC is crucial for understanding its heterogeneity.
  • The identified molecular targets hold promise for developing targeted therapies.
  • Further research is warranted to translate these findings into clinical practice for improved TNBC treatment.

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.8K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
6.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
80
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K